Hybrid approach holds promise for multi-vessel disease

04/29/2013 | Healio

Three years after undergoing hybrid coronary revascularization, patients with multi-vessel disease do better than those treated with either percutaneous coronary intervention or bypass surgery alone, according to a study in the Journal of the American College of Cardiology.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY